The phrase ‘psycholytic therapy’ was coined by Ronald A. Sandison, literally meaning soul-dissolving. In contrast to psychedelic therapy, psycholytic therapy places more emphasis on the psychotherapy than the substance. It typically consists of a low-to-medium dose of a psychedelic compound alongside more therapy sessions than its counterpart.

In this month’s episode of the Psychedelics in Medicine Podcast (PiMPOD), Dr Torsten Passie and Ben Clayden discuss psycholytic therapy. What is the history of substance assisted therapies? What are its differences to psychedelic therapy? Has it shown therapeutic relevance and efficacy? These and much more our discussed in today episode.

Dr Passie is a German psychiatrist, professor at Hannover Medical School and is an expert in altered states of consciousness. Torsten has performed clinical and experimental studies numerous psychoactive and psychedelic compounds ranging from nitrous oxide, to MDMA to ketamine.

Ben Clayden is the creator and owner of this Podcast. He is a student at the University of York studying Natural Sciences specialising in Neuroscience. He is co-chair for the Drug Science Student Society Network as well as the president of his University’s Psychedelics in Medicine Society.

Psychedelics, LSD, Psilocybin, MDMA, Therapy, Doctors, Neuroscience, Medicine Mental Health, Depression, Anxiety, PTSD, Wellbeing, Psycholytic

Useful Links

INSTAGRAM - https://www.instagram.com/psymedpod/

LINKTREE - https://linktr.ee/psymedpod

RSS - https://rss.com/podcasts/psymedpod/